✦ LIBER ✦

627 GI-5005 IMMUNOTHERAPY PLUS PEG-IFN/RIBAVIRIN VERSUS PEG-IFN/RIBAVIRIN IN GENOTYPE 1 CHRONIC HCV SUBJECTS; PRELIMINARY PHASE 2 EVR ANALYSES

✍ Scribed by E.J. Lawitz; T.D. Boyer; G.T. Everson; I.M. Jacobson; W. Lee; J.G. McHutchison; P.J. Pockros; M.L. Shiffman; J.M. Vierling; S. Cruickshank; T.C. Rodell; D. Apelian

Book ID: 117377635
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 117 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60629-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

277 GI-5005 THERAPEUTIC VACCINE PLUS PEG

277 GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN IMPROVES BIOPSY NECRO-INFLAMMATORY SCORES AND ALT NORMALIZATION AT 48 WEEKS VERSUS PEG-IFN/RIBAVIRIN IN GENOTYPE 1 CHRONIC HCV PATIENTS

✍ J.G. McHutchison; Z.D. Goodman; G.T. Everson; I.M. Jacobson; T.D. Boyer; E.R. Sc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

2006 GI-5005 THERAPEUTIC VACCINE PLUS PE

2006 GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN SIGNIFICANTLY IMPROVES VIROLOGIC RESPONSE AND ALT NORMALIZATION AT END-OF-TREATMENT AND IMPROVES SVR24 COMPARED TO PEG-IFN/RIBAVIRIN IN GENOTYPE-1 CHRONIC HCV PATIENTS

✍ Jacobson, I.M.; McHutchison, J.G.; Boyer, T.D.; Schiff, E.R.; Everson, G.T.; Poc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

1181 PHARMACOGENOMIC ANALYSIS REVEALS IM

1181 PHARMACOGENOMIC ANALYSIS REVEALS IMPROVED VIROLOGIC RESPONSE IN ALL IL-28B GENOTYPES IN NAIVE GENOTYPE 1 CHRONIC HCV PATIENTS TREATED WITH GI-5005 THERAPEUTIC VACCINE PLUS PEG-IFN/RIBAVIRIN

✍ McHutchison, J.G.; Thompson, A.J.; Jacobson, I.M.; Boyer, T.D.; Schiff, E.R.; Ev 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB